• Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Author Archive - Market Exclusive

drug factory, researcher,

Why The Corbus Pharmaceuticals Holdings Inc (CRBP) Cystic Fibrosis Results Are Very Positive

Last week, Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) announced data from a Phase II study of its lead development asset Anabasum. The data appeared...

Keep Reading →

April 4 - News, Stock Analysis - Comments

Cannabis Space Continues To Shine As Latest IPO Therapix BioSciences (TRPX) Oversubscribed

The cannabis space has been one of the most closely watched, and the most active, sectors across the last twelve months. The Viridian Cannabis Stock Index...

Keep Reading →

March 22 - News, Stock Analysis - Comments

Biopharmaceutical, Bio-technology

FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following Rejection Of Hyperkalemia Drug

AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S. Food and Drug Administration for ZS...

Keep Reading →

March 21 - News, Stock Analysis - Comments

10 Best Small-Cap Biotech Stocks Under $10 in 2021s, Puns, and Humor Quotes Ever

Nektar Therapeutics (NKTR): Here’s What Just Happened

Nektar Therapeutics (NASDAQ:NKTR) is one of the week’s biggest winners in biotech so far, with the company soaring during the Monday session on the...

Keep Reading →

March 21 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals

In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million...

Keep Reading →

March 20 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined...

Keep Reading →

March 20 - News, Stock Analysis - Comments

10 Best Small-Cap Biotech Stocks Under $10 in 2021

Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap

At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha. The drug first...

Keep Reading →

March 20 - News, Stock Analysis - Comments

Easiest Md/PhD Programs to Get Into

Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study

Positive results for the Phase III study meant to test the experiences of patients using the eye insert known as Dextenza to relieve pain in a post-surgical...

Keep Reading →

March 17 - News, Stock Analysis - Comments

easiest countries to get oxycodone prescribed

Seres Therapeutics Inc (MCRB) Announces New “Poop Pill” Phase 2 Study

Plans to start a new Phase II study of SER-109, branded ECOSPOR III, have been announced by Seres Therapeutics Inc (NASDAQ:MCRB). The drug is meant to...

Keep Reading →

March 17 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Biotech Movers On Friday: Neurotrope Inc (NTRP) And PTC Therapeutics, Inc. (PTCT)

Here’s a look at some of the week’s biggest movers in biotech, what’s moving them, and where we expect things to go early next week and beyond....

Keep Reading →

March 17 - Market Movers, News, Stock Analysis - Comments

Most Advanced Countries in Medicine

Transcatheter Device By Medtronic PLC (MDT) Gets FDA Nod

The Melody Transcatheter Pulmonary Valve that has been developed by Medtronic PLC. Ordinary Shares (NYSE:MDT) has been approved by the U.S. Food and Drug...

Keep Reading →

March 17 - News, Stock Analysis - Comments

Merck MRK

Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug

Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc. (NYSE:MRK) claiming that its shingles vaccine, Zostavax...

Keep Reading →

March 16 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face Of Stiff Competition

After recently getting the approval of the U.S. Food and Drug Administration, Novartis AG (ADR) (NYSE:NVS) has announced that a flexible pricing system...

Keep Reading →

March 16 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)

Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression. AstraZeneca...

Keep Reading →

March 16 - News, Stock Analysis - Comments

Biopharmaceutical, Bio-technology

Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next

After struggling throughout the latter half of 2016 with various development and regulatory pressures, Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has...

Keep Reading →

March 16 - News, Stock Analysis - Comments

lab, laboratory, clinic, clinical, scientist, researching, research, chemist, medical, man, male, specialist, focus, chemistry, test, science

Aurinia Pharmaceuticals Inc (AUPH) In A Common Shares Public Offering To Raise Over $150 Million

In the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) public offering, common shares totaling 22,300,000 will be offered at $6.75 a share. The biopharmaceutical...

Keep Reading →

March 15 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)

It’s been a big week for PARP inhibitors. AstraZeneca PLC (ADR) (NYSE:AZN) just put out data from a phase 3 investigation of its lead PARP asset Lynparza...

Keep Reading →

March 15 - News, Stock Analysis - Comments

CVS Health Corp (CVS) Pledges Funds For Youth Anti-Smoking Campaign

In its efforts to contribute to a generation that is tobacco-free, CVS Health Corp (NYSE:CVS) has devoted $50 million for a five-year program. The drug...

Keep Reading →

March 14 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

AstraZeneca PLC (ADR) (AZN) Rejected Drugs To Be Reconsidered

AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs, as they could possess potential in curing a disease they were not initially...

Keep Reading →

March 14 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (BLRX) And AMAG Pharmaceuticals, Inc. (AMAG)

It’s been a busy quarter in the biotechnology space, but it’s not over yet. This month promises to bring with it a flurry of end of quarter catalysts...

Keep Reading →

March 14 - News, Stock Analysis - Comments

Valeant VRX contact lenses women finger eye care vision medical

3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX)

Pershing Square Capital Management, managed by Bill Ackman, sold its entire stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) on Monday. The investor...

Keep Reading →

March 14 - Hedge Funds, News, Stock Analysis - Comments

Best Cities for Pale Skin

Food And Drug Administration Accepts Allergan PLC (AGN) Vraylar For Review As A Supplemental Drug

Allergan plc Ordinary Shares (NYSE:AGN) has announced that an application to have new clinical data for Vraylar evaluated has been accepted by the Food...

Keep Reading →

March 13 - News, Stock Analysis - Comments

Coverage For Medtronic PLC (MDT) Micra Approved By Centers For Medicare & Medicaid

The Centers for Medicare & Medicaid Services (CMS) has granted approval to the Micra Transcatheter pacemaker (Micra TPS) that is manufactured by Medtronic...

Keep Reading →

March 13 - News, Stock Analysis - Comments

Biopharmaceutical, Bio-technology

Is The Radius Health Inc (RDUS) Dip A Discount Opportunity?

Every so often, a biotech company takes a hit on some news that seems negative, and at first glance is, but is likely only temporary in terms of impact...

Keep Reading →

March 13 - News, Stock Analysis - Comments

Medical devices, medical equipment

German Court Rules In Favor Of Boston Scientific Corporation (BSX) In Patent Case Against Edwards Lifesciences Corp (EW)

A court in Germany has ruled that patents held by Boston Scientific Corporation (NYSE:BSX) were infringed upon by Edwards Lifesciences Corp (NYSE:EW)....

Keep Reading →

March 10 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here’s What’s Moving Immunomedics, Inc. (IMMU) And Ocera Therapeutics Inc (OCRX)

Yet again we’ve had a pretty busy week in the biotech space. Macro forces are coming in to play, and combined with what proved a busy release calendar...

Keep Reading →

March 10 - Market Movers, News, Stock Analysis - Comments

Access For Reversal Drug For Opioid Overdose Expanded By CVS Health Corp (CVS)

CVS Health Corp (NYSE:CVS) has announced that patients in four more states who don’t have an individual prescription will be allowed to get naloxone...

Keep Reading →

March 10 - News, Stock Analysis - Comments

Easiest Md/PhD Programs to Get Into

Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors

Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma...

Keep Reading →

March 10 - News, Stock Analysis - Comments

Pfizer PFE pharmaceutical stock

Pfizer Inc. (PFE) Reportedly In Talks To Expand Plant In Lee County

Reports allege that Pfizer Inc. (NYSE:PFE) is holding talks with Lee County officials as it considers investing $100 million to expand a plant located...

Keep Reading →

March 8 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Positive Results For AbbVie Inc (ABBV) Humira Biosimilar Reported By Novartis AG (ADR) (NVS)

A Phase III study has shown that GP2017, which is manufactured by Sandoz, a unit of Novartis AG (ADR) (NYSE:NVS), has shown positive results as a Humira...

Keep Reading →

March 8 - News, Stock Analysis - Comments

Biopharmaceutical, Bio-technology

Answering The Important Aurinia Pharmaceuticals Inc (AUPH) Questions

Last week we looked at development stage biotechnology company Aurinia Pharmaceuticals Inc (NASDAQ:AUPH). At the time of our coverage, the company had...

Keep Reading →

March 8 - News, Stock Analysis - Comments

Merck MRK

FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)

The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE...

Keep Reading →

March 8 - News, Stock Analysis - Comments

drug factory, researcher,

Eli Lilly And Co (LLY) Taltz Has A Higher Response Rate Than Stelara For Psoriasis

Detailed results from the IXORA-S study have revealed that Taltz (ixekizumab) has superior efficacy compared to Stelara (ustekinumab). According to Eli...

Keep Reading →

March 8 - News, Stock Analysis - Comments

Easiest Md/PhD Programs to Get Into

Here’s What’s Next For TG Therapeutics Inc (TGTX)

TG Therapeutics Inc (NASDAQ:TGTX) is a big runner this week, with the company up close t 90% during Monday’s session alone out of the US. Chances are...

Keep Reading →

March 7 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Perrigo Company PLC (PRGO) Becomes The Latest Pharma Investigated Over Price Fixing

The prices of Perrigo Company plc Ordinary Shares (NYSE:PRGO) drugs used in skin treatments is being examined by law enforcement authorities. This is...

Keep Reading →

March 6 - News, Stock Analysis - Comments

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

In A Blow To AbbVie Inc (ABBV) Humira, Market For Biosimilars Opened Wide

Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court. The ruling was in favor...

Keep Reading →

March 6 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Two Biotechs To Watch This Week: Novan Inc (NOVN) And MannKind Corporation (MNKD)

Last week we saw plenty of volatility across the healthcare and biotechnology sectors, driven both by macro and micro factors. We’re expecting much...

Keep Reading →

March 6 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Novartis AG (ADR) (NVS) Fined And Some Products To Be Temporarily Suspended In South Korea

Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to...

Keep Reading →

March 3 - News, Stock Analysis - Comments

CVS Health Corp (CVS) Specialty Turns To New Record System For More Efficiency

Epic’s EHR systems has been selected for use by CVS Health Corp (NYSE:CVS) in its programs for care management. The new record system is expected to...

Keep Reading →

March 3 - News, Stock Analysis - Comments

biotechnological

Here’s What Happened To Karyopharm Therapeutics Inc (KPTI) And PTC Therapeutics, Inc. (PTCT)

The end of the week is upon us, and it’s been a bit of a wild ride in the biotech space. Macro forces have come into play from an industry wide sentiment...

Keep Reading →

March 3 - News, Stock Analysis - Comments

10 Best Small-Cap Biotech Stocks Under $10 in 2021

Perrigo Company PLC (PRGO) Drug Gets FDA Approval

The Food and Drug Administration has granted final approval to Axiron Topical Solution, a drug manufactured by Perrigo Company plc Ordinary Shares (NYSE...

Keep Reading →

March 2 - News, Stock Analysis - Comments

lab, laboratory, clinic, clinical, scientist, researching, research, chemist, medical, man, male, specialist, focus, chemistry, test, science

Corbus Pharmaceuticals Holdings Inc (CRBP) Share Offering Hints At $7 Floor With Threatening Short Squeeze

In most cases, equity financings below market are bad news for shareholders. There are exceptions though. Corbus Pharmaceuticals Holdings Inc (NASDAQ:...

Keep Reading →

March 2 - News, Stock Analysis - Comments

lawyer, court, courtroom, america, on, statement, view, legal, day, lawsuit, adult, talking, male, frowning, female, foreground, system, front, robes, of, woman, unsmiling,

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States

The number of states accusing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan N.V. (NASDAQ:MYL) for price collusion have risen as the list...

Keep Reading →

March 2 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA

President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S. Food and Drug Administration...

Keep Reading →

March 2 - News, Stock Analysis - Comments

Biopharmaceutical, Bio-technology

Patient Death Fears Allayed For Aurinia Pharmaceuticals Inc (AUPH), What’s Next?

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is a real winner towards the end of this week, on a fresh batch of data from its lead lupus study. The data...

Keep Reading →

March 2 - News, Stock Analysis - Comments

biotechnological

Perrigo Company PLC (PRGO) Sells Rights To Tysabri

The royalty stream that Perrigo Company plc Ordinary Shares (NYSE:PRGO) used to get from Tysabri has been sold to Royalty Pharma. Both companies are based...

Keep Reading →

March 1 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here’s What’s Next For Lexicon Pharmaceuticals, Inc. (LXRX) And Dynavax Technologies Corporation (DVAX)

Two companies have logged strong starts to the week in the biotech space so far, and both are moving on FDA driven catalysts. Here’s a look at these...

Keep Reading →

March 1 - News, Stock Analysis - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Priority Review Granted To Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Tardive Dyskinesia Drug

An application for a new drug by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been accepted by the Food and Drug Administration. Teva’s...

Keep Reading →

March 1 - News, Stock Analysis - Comments

Easiest Md/PhD Programs to Get Into

BioCryst Pharmaceuticals, Inc. (BCRX): A Discount Entry?

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has caught our attention in the biotech space as being a company that has had a bit of a strange start to...

Keep Reading →

March 1 - News, Stock Analysis - Comments

biotech research company, bio-technology companies

Heron Therapeutics Inc (HRTX) Sustol To Be Included In Antiemesis Guidelines By NCCN

In new guidelines, Heron Therapeutics Inc (NASDAQ:HRTX) has announced that Sustol will be included as an extended-release injection. A recommendation...

Keep Reading →

March 1 - News, Stock Analysis - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$202,411,166,000

David Einhorn

David Einhorn

Greenlight Capital

$922,283,000

George Soros

George Soros

Soros Fund Management

$4,481,502,000

Jim Simons

Jim Simons

Renaissance Technologies

$115,840,763,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$873,897,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$19,724,532,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$15,331,618,000

John Paulson

John Paulson

Paulson & Co

$3,129,243,000

David Tepper

David Tepper

Appaloosa Management LP

$5,758,450,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$2,017,669,000

Insider Monkey Small Cap Strategy
Most Read Posts
Dump Your Hedge Funds and Buy This Stock
World’s Most Expensive Desserts
The 10 Best Selling Products Online
The 10 Best Selling Items on Etsy
The 12 Most Profitable Small Businesses
The 10 Best-Selling Video Games of All Time
Lists

15 Fastest Growing Biotech Companies in the US

5 Fastest Growing Biotech Companies in the US

15 Most Valuable Alcohol Companies

5 Most Valuable Alcohol Companies

15 Most Valuable Asian Companies

5 Most Valuable Asian Companies

20 Most Valuable Companies In The World in February 2021

Top 15 Pharmaceutical Companies With Highest R&D Spending

Top 5 Financial Centers/Cities of The World

Top 15 Financial Centers/Cities of The World

15 Most Valuable Cloud Computing Companies

5 Most Valuable Cloud Computing Companies

15 Fastest-Growing Fintech Companies

5 Fastest-Growing Fintech Companies

15 Biggest Companies That Accept Bitcoin

15 Youngest Tech Billionaires

Top 15 Serial Entrepreneurs In The World

15 Most Powerful and Influential Companies

12 Most Influential Entrepreneurs in America

15 Richest People in Central and South America

10 Emerging Energy Technologies You Can Invest In Today

15 Richest People In Canada

15 Biggest Water Companies in the World

15 Biggest Acquisitions Of All Time

15 Fastest Growing Dividend Stocks

15 Biggest VC Companies in the World

5 Biggest VC Companies in the World

15 Biggest Trucking Companies in the World

15 Biggest Tech Hardware Companies in the World

5 Biggest Tech Hardware Companies in the World

15 Biggest Wine Companies in the World

25 Highest Earning Billionaires in 2020

15 Fastest-Growing Software Companies

15 Biggest Yogurt Companies in the World

Easily Digestible and Delicious Recipes For Elderly

5 Fastest-Growing Software Companies

5 Fastest-Growing Engineering Fields

15 Biggest Lithium Mining Companies in the World

15 Fastest-Growing Engineering Fields

15 Biggest Companies That Went Bankrupt

Top 10 Most Deadliest and Dangerous Snakes In the World

20 Most Deadliest and Dangerous Snakes In the World

10 Easiest Occupational Therapy Schools To Get Into

Top 5 Easiest Occupational Therapy Schools To Get Into

15 Biggest Money Transfer Companies in the World

5 Biggest Wine Companies in the World

15 Fastest Growing Franchises

15 Biggest Bribery Cases in Business History

25 Fastest Growing Mid size Cities in the US

10 Biggest Gay Events in the United States

Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.